These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 3822880)

  • 21. Antibacterial activity of cephamandole--a new antibiotic.
    Goyal P; Bhatia R; Baveja UK; Agarwal DS
    J Commun Dis; 1982 Jun; 14(2):130-3. PubMed ID: 6818272
    [No Abstract]   [Full Text] [Related]  

  • 22. Microbiological evaluation of cefoperazone, a new semisynthetic cephalosporin.
    Blandino G; Dubini F; Russo G; Cocuzza G
    Clin Ther; 1980; 3(Spec Issue):103-11. PubMed ID: 6446383
    [No Abstract]   [Full Text] [Related]  

  • 23. [Quinolone-resistant Escherichia coli in the health area of a 650-bed hospital].
    Fernández Fernández A; Lantero Benedito M; Gastañares Hernando MJ; Undabeitia Santisteban E; Fernández Santos F; Castaño Rodríguez A; Gil Fabra J; Martínez Castellanos F; Otero Mauricio G
    Actas Urol Esp; 1994 Jun; 18(6):634-8. PubMed ID: 7942213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An investigation of the antibacterial activity of cefoxitin against anaerobic and aerobic bacteria in vitro (author's transl)].
    Babić I; Jelić I; Stanojević D
    Lijec Vjesn; 1980; 102(7-8):414-6. PubMed ID: 7289718
    [No Abstract]   [Full Text] [Related]  

  • 25. Bacterial resistance to norfloxacin and other newer quinolones: pattern and prospects.
    Nalin DR
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S55-61. PubMed ID: 3280327
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quinolones: antimicrobials for the 90s].
    Timerman A
    AMB Rev Assoc Med Bras; 1987; 33(5-6):81-2. PubMed ID: 3502367
    [No Abstract]   [Full Text] [Related]  

  • 27. Increasing rates of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimens.
    Desgrandchamps D; Munzinger J
    Antimicrob Agents Chemother; 1989 Apr; 33(4):595-6. PubMed ID: 2729954
    [No Abstract]   [Full Text] [Related]  

  • 28. Ciprofloxacin Staphylococcus aureus resistance.
    Pane FJ; Ringer L; Child JA; Miller DM
    DICP; 1990 Apr; 24(4):439. PubMed ID: 2327119
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro evaluation of rosaramicin with special reference to the risk of resistance.
    Lacey RW
    J Antimicrob Chemother; 1981 Mar; 7(3):293-9. PubMed ID: 7275879
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibacterial study of substituted N-benzylidenediphenylamine-2-carboxylic acid hydrazides.
    Bahadur S; Goel AK; Imam SA
    Hindustan Antibiot Bull; 1975; 18(1-2):31-3. PubMed ID: 1236089
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized study comparing low dose ciprofloxacin and ofloxacin in the treatment of lower respiratory tract infections.
    Polubiec A; Jórasz I; Pietrzak J; Soszka A; Stepka K; Zaryn A
    Infection; 1994; 22(1):62-4. PubMed ID: 8181847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of ciprofloxacin, norfloxacin, and ofloxacin against multi-resistant Enterobacteriaceae.
    Niculescu E; Wagener H
    Chemioterapia; 1987 Jun; 6(2 Suppl):132-3. PubMed ID: 3509369
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evolution of fluoroquinolone sensitivity in Staphylococcus aureus isolated from hemocultures in a general hospital].
    Cogollos R; Alós JI; Gómez-Garcés JL
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):460. PubMed ID: 8260521
    [No Abstract]   [Full Text] [Related]  

  • 34. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN; Kohlhepp SJ; Slama KA; Grunkemeier G; Lewis G; Dworkin RJ; Slaughter SE; Leggett JE
    Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the effect of new fluoroderivatives of piperazinol-quinoline on clinical strains of aerobic and anaerobic bacteria].
    Dzierzanowska D; Ukraiński W; Piotrowska E; Kazmirowska Z; Pykiel M
    Pol Tyg Lek; 1986 Sep; 41(37):1180-3. PubMed ID: 3822880
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.